Skip to content

Wednesday, November 12, 2025

Latest:

p53 mutant R273H opens new avenues for future personalized cancer treatment
Looking for something different to eat for Thanksgiving this year? Try going vegetarian.
Healthy Habits: Dr. Punam Amin’s kids motivate her to stay healthy
The importance of criminal background checks on firearm purchases
Medical student-mentor teams in research: Anthony Allam and mentor Dr. Dorina Papageorgiou share their experience with SOAR

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

TopBP1

5D4 disrupts several molecular pathways, including MYC, that lead to cancer growth

October 26, 2023 5D4, Breast Cancer, cancer inhibitor, MYC, ovarian cancer, PARP inhibitor, Research, TopBP1

The findings strongly support the potential use of TopBP1 inhibitors as a targeted cancer therapy.

From the Labs: Image of the Month

From the Labs: Neurons in a Huntington’s brain

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951